title: Donor bone marrow infusions in conjunction with liver-islet allotransplantation in patients with type 2 diabetes.
authors.affiliation: Cell Transplant Center, University of Miami School of Medicine, Florida, USA.
authors.forename: R
authors.initials: R
authors.lastname: Alejandro
authors.forename: C
authors.initials: C
authors.lastname: Ricordi
authors.forename: M C
authors.initials: MC
authors.lastname: Angelico
authors.forename: J
authors.initials: J
authors.lastname: Nery
authors.forename: M
authors.initials: M
authors.lastname: Webb
authors.forename: L
authors.initials: L
authors.lastname: Fernandez
authors.forename: R
authors.initials: R
authors.lastname: Lehman
authors.forename: T
authors.initials: T
authors.lastname: Karatzas
authors.forename: L
authors.initials: L
authors.lastname: Olson
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
mesh_terms: D016026:Bone Marrow Transplantation; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D006442:Glycated Hemoglobin / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation; D008103:Liver Cirrhosis / Q000150:complications*; D014184:Transplantation, Homologous
chemical_list: D006442:Glycated Hemoglobin; D007328:Insulin